176 related articles for article (PubMed ID: 3557728)
1. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
[TBL] [Abstract][Full Text] [Related]
2. Disposition kinetics of dibekacin in patients with renal failure and in patients undergoing hemodialysis.
Arancibia A; Baillarie D; Bravo M; Chávez J
Int J Clin Pharmacol Ther; 1995 Nov; 33(11):623-7. PubMed ID: 8688988
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
Viotte G; Leroy A; Godin M; Fillastre JP
Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of dibekacin in subjects with normal renal function].
Thauvin C; Borsa F; Leroy A; Humbert G
Nouv Presse Med; 1982 Nov; 11(46):3410-3. PubMed ID: 7155848
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
[TBL] [Abstract][Full Text] [Related]
6. Gentamicin disposition in children with chronic renal failure.
Berry PL; Kearns GL; Brown RD; Ritschel WA; Thompson GA; McEnery PT
Pediatr Pharmacol (New York); 1982; 2(4):257-73. PubMed ID: 6927126
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
8. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral cefatrizine in patients with impaired renal function.
Couet W; Fauvel JP; Laville M; Pozet N; Fourtillan JB
Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):213-7. PubMed ID: 1869342
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of azlocillin in healthy subjects.
Leroy A; Humbert G; Fillastre JP
Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
Moukhtar I; Nawishy S; Sabbour M
Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mecillinam after a single intravenous dose in patients with impaired renal function.
Moukhtar I; Nawishy S; Sabbour M
Int J Clin Pharmacol Res; 1987; 7(1):59-62. PubMed ID: 3583488
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
[TBL] [Abstract][Full Text] [Related]
17. Butofilolol pharmacokinetics in chronic renal insufficiency.
Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
Nawishy S; Moukhtar I; Sabbour M
Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of norfloxacin in chronic renal failure.
Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
